Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-10-31
2010-11-30
Rawlings, Stephen L (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S387100, C530S387300, C530S387700, C424S130100, C424S133100, C424S138100, C424S145100
Reexamination Certificate
active
07842790
ABSTRACT:
Disclosed are an antibody against human para-thyroid-hormone-related protein, a DNA coding for the antibody, a recombinant vector containing the DNA, a transformant transformed with the recombinant vector, a method for preparation of the antibody, and uses of the antibody.
REFERENCES:
patent: 4771124 (1988-09-01), Rosenblatt et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5001223 (1991-03-01), Rosenblatt et al.
patent: 5217896 (1993-06-01), Kramer et al.
patent: 5618920 (1997-04-01), Robinson et al.
patent: 5626845 (1997-05-01), Yoneda et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5849695 (1998-12-01), Cohen et al.
patent: 5993817 (1999-11-01), Yoneda et al.
patent: 0 293 130 (1988-11-01), None
patent: 0 293 158 (1988-11-01), None
patent: 0 449 405 (1991-10-01), None
patent: 0 619 324 (1994-10-01), None
patent: 0 811 383 (1997-12-01), None
patent: 0 878 201 (1998-11-01), None
patent: 0 962 467 (1999-12-01), None
patent: 1 004 313 (2000-05-01), None
patent: 1 090 643 (2001-04-01), None
patent: 2-207099 (1990-08-01), None
patent: 4-502408 (1992-05-01), None
patent: 4-228089 (1992-08-01), None
patent: 7-165790 (1995-06-01), None
patent: 7-316195 (1995-12-01), None
patent: 11-80025 (1999-03-01), None
patent: 11-22240 (1999-08-01), None
patent: 2000-080100 (2000-03-01), None
patent: 89/11297 (1989-11-01), None
patent: 89/11298 (1989-11-01), None
patent: 90/07861 (1990-07-01), None
patent: 92/00753 (1992-01-01), None
patent: 92/17602 (1992-10-01), None
patent: 92/19759 (1992-11-01), None
patent: 93/13133 (1993-07-01), None
patent: 94/11523 (1994-05-01), None
patent: 96/03437 (1996-02-01), None
patent: 96/39184 (1996-02-01), None
patent: 96/22790 (1996-08-01), None
patent: 96/26737 (1996-09-01), None
patent: 96/33735 (1996-10-01), None
patent: 97/04312 (1997-01-01), None
patent: 98/13388 (1998-04-01), None
patent: 98/51329 (1998-11-01), None
patent: 99/57139 (1999-11-01), None
Sato et al. (J. Bone Mineral Res. 1993; 8: 849-860).
Sato et al. (Semin. Oncol. 2003; 30: 167-173).
Onuma et al. (Int. J. Cancer. 2005; 116: 471-478).
Ogata (Cancer. Jun. 15, 2000; 88: 2909-2911).
Iguchi et al. (J. Bone Mineral Metab. 2006; 24: 16-19).
Abou-Samra et al., “Expression Cloning of a Common Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide from Rat Osteoblast-Like Cells: A Single Receptor Stimulates Intracellular Accumulation of Both cAMP and Inositol Trisphosphates and Increases Intracellular Free Calcium,” Proceedings of the National Academy of Sciences, 89:2732-2736, 1992.
Baba, PTH/PTHrP, Clinical Calcium, 5:97-101, 1995, (English Translation).
Beck, et al., “Lipolytic Factors Associated with Murine and Human Cancer Cachexia,” Journal of the National Cancer Institute, 82:1922-1926, 1990.
Belyavsky, et al., PCR-Based cDNA Library Construction: General cDNA Libraries at the Level of a Few Cells, Nucleic Acids Research, 17:2919-2933, 1989.
Benet, et al., Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, and Elimination, In: The Pharmacological Basis of Therapeutics, 8thedition, pp. 3-32, 1990.
Burtis, Parathyroid Hormone-Related Protein: Structure, Function, and Measurement, Clinical Chemistry, 38:2171-2183, 1992.
Carter, et al., Humanization of an Anti-p 185HERZAntibodyfor Human cancer Therapy, Proceedings of the National Academy of Sciences, 89:4285-4289, 1992.
Chirgwin, et al. Isolation of Biologically Active Ribonucleic Acid From Sources Enriched in Ribonuclease, Biochemistry, 18:5294-5299, 1979.
Coleman, et al., Biochemical Mechanisms of Parathyroid Hormone Action, The Parathyroids, Basic and Clinical Concepts, 239-258, 1994.
Cuisinier, et al., Mechanisms that Generate Human Immunoglobulin Diversity Operate From the 8thWeek of Gestation in Fetal Liver, European Journal of Immunology, 23:110-118, 1993.
Dariavach, et al., Human Immunoglobulin Cλ6 Gene Encodes the Kern+Oz λ Chain and Cλ4 and Cλ5 are Pseudogenes, Proceedings of the National Academy of Sciences, 84:9074-9078, 1987.
Deftos et al., Utilization of a Potentially Universal Downstream primer in the Rapid Identification and Characterization of Vλ Genes from Two New Human Vλ Families, Scanginavian Journal of Immunology, 39:95-103, 1994.
Chomczynsk et al., Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction, Analytical Biochemistry, 162:156-159, 1987.
Chothia, Canonical Structure for the Hypervariable Regions of Immunoglobulins, Journal of Molecular Biology, 196:901-917, 1987.
Co, et al., Chimeric and Humanized Antibodies with Specificity for the CD33 Antigen, The Journal of Immunology, 148:1149-1154, 1992.
Co, et al., Humanized Antibodies for Antiviral Therapy, Proceedings of the National Academy of Sciences, 88:2869-2873, 1991.
De St. Groth, et al., Production of Monoclonal Antibodies: Strategy and Tactics, Journal of Immunological Methods, 35:1-21, 1980.
Dworkin, et al., Dietary Intake in Patients with Acquired Immunodeficiency Syndrom (AIDS), Patients with AIDS-Related Complex, and Serologically Positive Human Immunodeficiency Virus Patients: Correlations with Nutritional Status, Journal of Parenteral and Enternal Nutrition, 14:605-609, 1990.
Farmer, et al., Speculations on the Design of Nonpeptidic Peptidomimetics, TIPS, 4:362-365, 1982.
Frohman, et al., Rapid Production of Full-Length cDNAs from Rare Transcripts: Amplification Using a Single Gene-Specific Oligonucleotide Primer, Proceedings of the National Academy of Sciences, 85:8998-9002, 1988.
Galfre, et al., Rat x Rat Hybrid Myelomas and A Monoclonal Anti-Fd Portion of Mouse IgG, Nature, 277:131-133, 1979.
Gorman, et al., Reshaping a therapeutic CD4 Antibody, Proceedings of the National Academy of Sciences, 88:4181-4185, 1991.
Hammond, et al., Respitory Muscle Strenth in Congestive Heart Failure, Chest, 98:1091-1094m 1990.
Hardman, et al, (ed.), Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Section XIII, Hormones and Hormone Anatgonists, McGraw-Hill Co. (USA) 9thed., at 1528-1529, 1995.
Hardman, et al., (ed.), Agents Affecting Calcification and Bone Turnover in Goodman and Gilman's, The Pharmacological Basis of Therapeutics, McGraw-Hill Co. (USA) 9thed., at 1523-1524, 1995.
Harris, et al., Therapeutic Antibodies, The Coming of Age, TIBTECH, 11:42-44, 1993.
Ikeda, Molecular Biology of Parathyroid Hormone-Related Peptide, Nihon Rinshou, 53:37-45, 1995.
Ikeda, Development of novel Endocrinotherapy Targeting Cancer and Paraneoplastic Syndromes, Progress in Clinical Pharmacology, 16:155-161, 1995 English Abstract.
Jones, et al., Rapid PCR-Cloning of Full-Length Mouse Immunoglobulin Variable Regions, Bio/Technology, 9:88-89, 1991.
Juppner et al., A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide, Science, 254:1024-1026, 1991.
Kaji, et al, Role of Dual Signal Transduction Systems in the Stimulation of bone Resorption by Parathyrod Hormone-related Peptide, The Direct Involvement of cAMP-Dependent protein Kinase, Hormone and Metabolic Research, 25:421-424, 1993.
Kajimura et al, Toxohormones Responsible for Cancer Cachexia Syndrom in Nude Mice Bearing Human Cancer Cell Lines, Cancer Chemotherapy and Pharmacology, 38:S48-S52, 1996.
Karlsson, et al., Kinetic Analysis of Monoclonal Antibody-Antigen Interactions with a New Biosensor Based Analytical System, Journal of Immunological Methods., 145:229-240, 1991.
Kato, et al., Incisor Change Induced by Excessive PTHrP in Rats, Abstracts of 16thMeeting of Japanese Society of Toxicologiv Pathology, p. 17, 2000, English Translations.
Kearney, et al., A New Mouse Myeloma Cell Line that has Lost Immunoglobullin Expression But Permits the Construction of Antibody-Secreting Hybrid Cell Lines, The Journal of Immunology, 123; 1548-1550, 1979.
Kemp et al., Parathyroid Hormone-Related Protein of Malignancy: Active Synthetic Fragments, Science 238:1568-1570, 1987.
Kettleborough, et al., Humanization of a Mounse Monoclonal Antibody by CDR-Grafting: The Importance of Framework Residues on Loop Conformation, Protein Engineering, 4
Sato Koh
Wakahara Yuji
Yabuta Naohiro
Chugai Seiyaku Kabushiki Kaisha
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Rawlings Stephen L
LandOfFree
Antibodies against human parathyroid hormone related protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against human parathyroid hormone related protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against human parathyroid hormone related protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4230654